The global Point of Care (PoC) diagnostics market is expected to reach US$ 24.70 billion by 2028, according to a new study by Polaris Market Research. The report “Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory); By Product; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global
Point of Care (PoC) diagnostics market is driven by continuous technological
advancement in the form of miniaturization of devices, growing preference of
patients towards home care, and consistent decline in prices due to inflow of
innovative market players. Price reduction increases product penetration, owing
to higher affordability among consumers.
The growing
prevalence of target diseases such as cancer, diabetes, cardiovascular diseases
and infectious diseases is expected to drive Point of Care (PoC) diagnostics
industry. Cardiovascular diseases are one of the most fatal disorders and are
the leading cause of death across the globe. The high presence of unmet medical
needs pertaining to this disease and the subsequent rise observe in patient
awareness levels in this region is expected to boost the demand for Point of
Care (PoC) diagnostics.
Download
Sample Copy : https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample
Segment Highlights
·
Glucose
testing segment accounted for the largest revenue share in 2020. Regular
glucose testing is of paramount importance for diabetic patients. As per the
Diabetes Control and Complications Trial, the use of blood glucose monitors
leads to lesser disease complications. Point of Care (PoC) glucose monitors
assisting in periodic monitoring of blood glucose helps doctors decide suitable
treatment patterns.
·
Clinics were
the largest end-use segment accounting for major market share in 2020. High
procedure volumes associated with these establishments is one of the primary
reasons attributing to its large share.
·
North
America was the largest regional market for revenue generation in from Point of
Care (PoC) devices in 2020. Growing geriatric population base and the presence
of higher medical expenditure levels are some key factors attributing to its
largest share.
·
The leading
players in the point of care (PoC) diagnostic market include Sekisui
Diagnostics LLC, Trinity Biotech PLC, International Technidyne Corporation
(ITC), Nipro Diagnostics Inc, Becton Dickinson & Company, Danaher
Corporation, Siemens Healthcare GmbH, Roche Ltd.
List of Key Players of Point of Care (PoC) Diagnostics Industry
- Roche Diagnostics
- EKF Diagnostics
- Siemens
Healthineers
- Chembio Diagnostic
Systems
- Johnson &
Johnson
- Abbott Laboratories
- Becton, Dickinson
and Company
- Danaher Corporation
- Quidel Corporation
- Nova Biomedical
- PTS Diagnostics
- Sekisui
Diagnostics.
- Others
For
Further Insights and Segment-Specific Information, Contact a Market Analyst at
: https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-customization
Polaris
Market Research has segmented the Point of Care (PoC) diagnostics market report
on the basis of product,
platform, end-use, and region
Point of
Care (PoC) Diagnostics, Product Outlook (Revenue – USD Million, 2016 – 2028)
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Infectious Diseases
- HIV
- Clostridium
Difficile
- HBV
- Pneumonia or
Streptococcus Associated Infections
- Respiratory
Syncytial Virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and
Drug-Resistant TB
- HSV
- Others
- Cardiac Markers
- Thyroid Stimulating
Hormone
- Hematology
- Primary Care
Systems
- Decentralized
Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood
Gas/Electrolytes
- Ambulatory
Chemistry
- Drug Abuse Testing
- Urinalysis
Point of
Care (PoC) Diagnostics, Platform Outlook (Revenue – USD Million, 2016 – 2028)
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular
Diagnostics
- Immunoassays
Point of
Care (PoC) Diagnostics, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Clinics
- Physician Office
- Pharmacy &
Retail Clinics
- Non-practice
Clinics
- Urgent Care Clinic
- Hospitals
- Home
- Assisted Living
Healthcare Facilities
- Laboratory
Point of Care (PoC) Diagnostics Regional Outlook (Revenue
– USD Million, 2016 – 2028)
·
North
America (U.S., Canada)
·
Europe
(France, Germany, UK, Italy, Spain, Netherlands, Austria)
·
Asia Pacific
(Japan, China, India, Malaysia, Indonesia, South Korea)
·
Latin
America (Brazil, Mexico, Argentina)
·
Middle East
& Africa (Saudi Arabia, UAE, Israel, South Africa)
